Research Article | | Peer-Reviewed

Anti-Staphylococcus Aureus Guide Isolation of Compounds from the Fruits of Ziziphus Mauritiana

Received: 8 December 2025     Accepted: 12 January 2026     Published: 30 January 2026
Views:       Downloads:
Abstract

The present work deals with the isolation, purification and characterization of secondary metabolites of the fruits of Ziziphus mauritiana and the evaluation of their biological activity against Staphylococcus aureus. A plant from the Rhamnaceae family, widely used in the Cameroonian and Tchadian traditional pharmacopoeia for the treatment of various diseases such as food poisoning, pneumonia, urinary tract infections, and skin infections such as wounds and ulcers. Our investigations focused on the methanol/dichloromethane (MeOH/DCM, 1:1) extract of the fruits of Ziziphus mauritiana. Alkaloidal treatment was performed on this extract, and we obtained four (04) fractions: two non-alkaloid fractions, F1 (DCM), F2 (EtOAc), and two alkaloid fractions, F3 (DCM) and F4 (EtOAc). Using usual chromatographic methods (CC, CCM), we isolated from the alkaloidal fraction F3, two compounds 1 and 2, and four compounds 3, 4, 5, 6 from the non-alkaloid fraction F1, the hexane fraction. From these compounds, three (03) were fully characterized using spectroscopic methods 1H and 13C NMR (1 and 2 dimensions) and by comparison of their spectral data with those of the literature. These are: Sanjoinenine 1, betulinic acid 3, and epicatechin 4. The crude extract as well as fraction, and some isolated compounds were evaluated in vitro by the liquid microdilution method described by CLSI, against two strains of Staphylococcus aureus: S. aureus ATCC25923, S. aureus ATCC43300, and a Clinical isolate. The crude extract, fractions F1 and F4, were the most active fractions tested against the strain S. aureus ATCC 25923, with a MIC of 15.6, 62.5, and 15.6 µg/mL, respectively, while the other fractions (F2 and F3) showed moderate activity against the same strain. Fraction F2 is not active. For the S. aureus ATCC 43300, all the fractions have a weak activity, and for the clinical isolate, only ZSA shows a good activity with a MIC of 62.5 µg/mL, and the others show a moderate activity.

Published in American Journal of Applied Chemistry (Volume 14, Issue 1)
DOI 10.11648/j.ajac.20261401.11
Page(s) 1-10
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2026. Published by Science Publishing Group

Keywords

Ziziphus Mauritiana, Staphylococcus Aureus, Sanjoinenine 1, Betulinic Acid 3, Epicatechin 4

1. Introduction
Staphylococcus aureus is the most dangerous of the many Staphylococci commonly found. Among the diverse multidrug-resistant bacteria, methicillin-resistant Staphylococcus aureus is probably the best-known resistant bacterium that has riveted intense scientific and political interest globally due to the limited spectrum of antibiotics for its effective treatment . Recent estimates of the World Health Organization revealed that the combined prevalence of MRSA in a diverse population of the African region is between 12 and 80% . In Chad, Cameroon, and many other countries in Africa, the prevalence of MRSA has been slowly rising over the past few decades. In most of the hospitals, antibiotic treatment is not streamlined as per the microbiological culture data. Consequently, MRSA strains are becoming resistant not only to β-lactams but also to multiple antimicrobial agents, such as macrolides, aminoglycosides, fluoroquinolones, and . From this standpoint, it is desirable to develop new antibiotic agents with reduced side effects and affordable to all.
Since immemorial time, the plant kingdom has catered to humans' need by providing a variety of drugs. Among them, terrestrial flora constitutes a prolific source of bioactive constituents. Plants synthesize a wide variety of metabolites to safeguard themselves and to maintain homeostasis in their environment. Investigations on naturally occurring antibiotic compounds from terrestrial plants have been carried out for more than a century . Hitherto, more than 200,000 natural products have been recorded from diverse species of flora . It has been purported that secondary metabolites from medicinal plants have minimal adverse reactions and can also repress the growth of pathogens by diverse mechanisms of action than the currently used synthetic antibiotics. Thus, medicinal plants such as Ziziphus, taken traditionally as decoction, tea, or infusion against bacterial diseases, may be welcome as a way to be explored.
The genus Ziziphus is known for its medicinal properties as a hypoglycemic, hypertensive, antiinflammatory, antimicrobial, antioxidant, antitumor, and liver protective agent and as an immune system stimulant . According to Dr. Nidal A. Jaradat, in 2005, Ziziphus is used as food, a diuretic, for teeth decay, to increase hair growth, for antidiarrhea, and to decrease thirst .
Chemical studies carried out show that the genus Ziziphus, particularly the species mauritiana, fruits are nutritious, contain protein, carbohydrates, and vitamins. Carbohydrates constitute 80.6% in dry matter, particularly in starch (21.8%), sucrose (21.8%), glucose (9.6%), fructose (16%), and iron . It has been reported that we can also find some secondary metabolites such as alkaloids, flavonoids, triterpenes, and cyclopeptides, which are predominant and have been shown to occur in different amounts in most Ziziphus species . Several authors have worked on the subject, presenting different therapeutic forms or other aspects of the plant and its fruit .
2. Materiel et Method
2.1. General Experimental Procedures
Melting points were measured on a standard heating block melting point apparatus. IR spectra were recorded on a Bruker Fourier transform/infrared (ATR) spectrophotometer. HR-ESI-MS spectra were measured with a FTHRMS-Orbitrap (Thermo-Finnigan) mass spectrometer. 1D (1H, 13C) and 2D (1H-1H-COSY, HSQC, HMBC) NMR spectra were recorded in deuterated solvents on a Bruker ARX 600 (1H 600 MHz and 13C 150 MHz). NMR spectrometer equipped with a 5 mm cryoprobe. All chemical shifts were measured in parts per million (ppm) using a residual solvent signal as secondary reference relatively to tetramethylsilane (TMS) as internal standard, while coupling constants (J) are given in Hz. Solvents were distilled prior to use. Analytical grade solvents were used for LC-MS. Column chromatography (CC) was performed using Merck MN silica gel 60 M (0.04-0.063 nm) and thin layer chromatography (TLC) was performed on aluminum silica gel 60 F254 (Merck) precoated plates (0.2 mm layer thickness). Spots were visualized on TLC either by UV lamp (254 and 365 nm) or by heating after spraying with 20% H2SO4 (v/v) solution. Different mixtures of n-hexane, EtOAc, DCM and MeOH were used as eluting solvents.
2.2. Plant Material
The seeds of Ziziphus mauritiana were collected in June 2021 at Ndjamena, a locality of Tchad, and were identified by Dr. ESSONO, a botanist. A specimen has been deposited at the National Herbarium.
2.3. Preparation of Stocks Solution of Extracts, Compounds and Reference Antibacterial
The antibacterial activity of extracts, fractions, and isolated compounds was performed using micro-dilution according to protocol M09-A7, The antibacterial activity of extracts, fractions and isolated compounds was performed using micro-dilution according to protocol M09-A7, coupled with a resazurin-based assay. Indeed, a serial dilution of extracts/fractions, compounds, and ciprofloxacin was performed in Muller Hinton Broth (Sigma Aldrich) to have different concentration ranges from 1000 to 1.95 µg/mL, from 125 to 0.48 µg/mL, and from 0.25 to 0.0078 µg/mL, respectively. The final bacteria load was 5 × 10^5 CFU/mL with the final volume of 200 µL. Ciprofloxacin was used as a positive control. Negative control constituted the culture medium and bacteria suspension, while sterility control was constituted with only culture media. All the plates were covered and incubated for 24 hrs at 37°C. At the end of the incubation period, 20 µL of freshly prepared resazurin (0.15 mg/mL) was added into each well and re-incubated under the same conditions for 30min. The MIC was defined as the smallest concentration of extracts, fractions, or isolated compounds from which there is no change in coloration from blue to pink, corresponding to the absence of visible bacterial growth.
3. Results and Discussion
This study aimed to perform bio-guided isolation of the dichloromethane/methanol extract of the fruits of Ziziphus mauritiana. Extract and fractions were tested against two references strains of S. aureus namely aureus ATCC25923, S. aureus ATCC43300 and a clinical isolates S. aureus CPC. The following cut offs were used to classify the activity of samples: very active when MIC < 100 μg/ml; significantly active when 100 ≤MIC≤512 μg/ml; moderately active when 512 <MIC ≤2048 μg/ml; weakly active if MIC >2048 μg/ml and not active when MIC >10 000 μg/ml. The fruits crude extract exhibited significant activity with MICs values at 15.6, 62.5 and 15.6 µg/ml respectively. The crude extract was fractionated using Liquid partition. Four fractions were obtained and labeled from F1 to F4. (Table 1).
Table 1. MIC values of anti-Staphylococcus aureus tests obtained on extract and fractions.

S. aureus ATCC25923

S. aureus ATCC43300

S. aureus Clinical isolate

ZSA

15.6

125

62.5

F1

-

-

-

F2

250

500

250

F3

15.6

500

125

F4

125

500

250

SA ATCC 25923: Staphylococcus aureus AT 25923, SA ATCC 43300: Staphylococcus aureus ATCC 43300. ZSA: Crude extract, F1: non alkaloid fraction (DCM), F2: non alkaloid fraction (EtOAc), F3: alkaloid fraction (DCM), F4: alkaloid fraction (EtOAc).
The results obtained show that the crude extract (ZSA) and fraction F3 were the most active fractions tested against the strain S. aureus ATCC 25923, with a MIC of 15.6, 62.5, and 15.6 µg/ml, respectively, while the other fractions (F2 and F4) show moderate activity against the same strain; fraction F1 is not active. For the S. aureus ATCC 43300, all the fractions have a weak activity, and for the clinical isolate, only ZSA shows a good activity with a MIC of 62.5 µg/mL, and the others show a moderate activity. This can be explained by the synergetic effect of compounds inside the crude extract. These results could also be justified by the richness of the extract in different ingredients having several antibacterial modes of action. From our investigations on fractions F2 and F4 belonging to the fruits' crude extract, four compounds were characterizedSanjoinenine 1, betulinic acid 3 and epicatechin 4.
Figure 1. Characterized Sanjoinenine 1, betulinic acid 3 and epicatechin 4.
3.1. Identification of Sanjoinenine 1
Soluble in pyridine, compound 1 precipitates in hexane/ethyl acetate (25%) as a white powder. It responds positively to the Potassium tetraiodomercurate test: Valser-Mayer reagent, characteristic of alkaloids.
In its 13C NMR spectrum (150 MHz, Pyridine-d5), we observe:
1) Three (03) signals attributable to the amide carbonyls and appearing at δC 172.5 (C-7); 168.9 (C-4) and 165.2 (C-22); two of which participate in the formation of the cyclopeptide and the other exocyclic respectively.
2) Four (04) signals corresponding to sp2 hybridized carbons, respectively trans olefinic and ethylenic carbons at δC 140.9 (C-24); 130.6 (C-23) and 126.5 (C-2); 118.5 (C-1).
3) Two (02) signals attributable to carbons bound to heteroatoms, precisely to the oxygen atom and resonating at δC 156.8 (C-11) (bound to the aromatic ring) and 82.6 (C-9) (bound to an isopropyl group).
4) Signals from the aromatic region including two isochron signals attributable to the a’, b’ system of an aromatic ring and resonating at δC 127.8 and 129.1.
Figure 2. 13C NMR spectrum (150 MHz, Pyridine-d5) of compound 1.
Its 1H NMR spectrum (600 MHz, Pyridine-d5, Figure 10), presents:
1) Four (04) integrative signals for one (01) proton each, attributable to the aromatic protons involved in the formation of the 14-membered ring. These protons resonate in the aromatic region at δH 7.04 (1H, d, H-12); 7.14 (1H, d, 6Hz, H-13); 6.97 (1H, dd, 6Hz, H-15); 7.44 (1H, dd, 6Hz, H-16); respectively. The mutiplicities of these are in agreement with those compared to the literature review and described by Abu-Zarga et al. .
2) Two (02) signals attributable to ethylenic protons belonging to a ring and always resonating in the strong fields at δH 6.49 (1H, t, H-1) and 6.93 (1H, t, H-2).
3) Three (03) signals, all appearing as a doublet and attributable to heteroatom protons, especially those bound to the nitrogen atom, resonating at δH 7.67 (1H, d, H-3); 9.20 (1H, d, H-6); 9.84 (1H, d, H-21) respectively.
4) One doublet and another doublet of doublet signal attributable to ethoxy and methoxy protons respectively appearing at δH 5.41 (1H, dd, (6; 0) Hz, H-8); 5.37 (1H, dd, (6; 0) Hz, H-9).
5) One (01) multiplet signal attributable to the proton bound to diastereoisotopic protons resonating at δH 4.69 (1H, m, H-5).
6) In the same 1H NMR spectrum (600MHz, Pyridine-d5, Figure 10), we observe:
7) Two (02) tripled signals, attributable to diastereoisotopic protons and resonant in weak fields at δH 1.59 (1H, dtd, H-17); 1.89 (1H, dtd, H-17’) each.
8) Two (02) doublets of one (01) proton each attributable to the trans olefinic protons of the cinnanomoyl group and appearing in the strong fields at δH 7.07 (1H, d, H-23) and 8.11 (1H, d, H-24) respectively.
9) Two multiplet signals corresponding to the methine protons, resonating at δH 1.79 (1H, m*, H-18) and 2.47 (1H, m*, H-33) each.
10) Four (04) methyl doublets appearing in the weak fields at δH 0.65 (3H, d, H-19); 0.65 (3H, d, H-20); 1.20 (3H, d, H-32); 1.23 (3H, d, H-33), each coupling with a methine proton; suggesting the presence of two leucine units.
All these data allowed us to highlight:
The carbon skeleton of a 14-membered cyclopeptide alkaloid (A).
Figure 3. The carbon skeleton of a 14-membered cyclopeptide alkaloid (A).
The 3-phenylpropenamide
Figure 4. The 3-phenylpropenamide.
The Methylpropan
Figure 5. The Methylpropan.
The isopropyl group
Figure 6. The isopropyl group.
Figure 7. 1H NMR spectrum (600 MHz, Pyridine-d5) of compound 1.
Figure 8. HSQC spectrum of compound 1.
3.2. Determination of the Positions of Groups B, C and D
Figure 9. HMBC 1H-13C spectrum..
At this stage of the discussion, it will only be necessary to determine the position of the B, C and D groups on the carbon skeleton of a 14-membered cyclopeptide alkaloid.
This was made possible by the interpretation of its HMBC 1H-13C spectrum. Indeed, the correlation spots observed between the H-17 proton and C-5, H-8 and C-22, H-31 and C-9 allowed us to position the B, C and D groups at C-8, C-5 and C-9 respectively. This was corroborated by the correlation spots observed on the COSY 1H-1H spectrum between protons H-8 and H-21 on the one hand and between protons H-17 and H-5 on the other hand.
Figure 10. Correlations observed on the COSY spectrum.
Figure 11. HMBC spectrum of compound 1.
All these spectroscopic data in agreement with those described by Tuenter E. et al., ; allow us to identify the carbon skeleton of a 14-membered cyclopeptide alkaloid of the frangulanine type. To these, we add the description made by Han B. H. et al., in 1982; and Abu-Zarga et al., identifying the structure of an alkaloid cyclopeptide, isolated other times from the species Ziziphus lotus (Abu-Zarga et al.) and Ziziphus vulgaris , under the name of Sanjoinenine with the gross formula C29H35N3O4. The scheme 9 is showing the diferent correlations between the atoms.
Table 2. Some Carbon-Proton correlations of compound 1 spectra comparing to that of the literature.

Position

δH (ppm); nH; m; J (Hz)

δC (ppm); (C5D5N)

δC (ppm); Lit) (CDCl3)

1.

7.07; 1H; d; 6

118.5

130.0

2.

6.93; 1H; t

126.5

132.7

3.

-

---

4.

-

168.9

165.6

5.

4.69; 1H; m*

52.9

52.9

6.

-

---

7.

-

172.5

171.9

8.

5.41; 1H; d; 6

56.4

55.6

9.

5.37; 1H; dd; 6-0

82.6

81.6

10.

-

---

11.

-

156.8

156.0

12.

7.04; 1H; d; 6

121.7

118.8

13.

7.14; 1H; d; 6

131.5

123.0

14.

-

131.6

131.6

15.

6.97; 1H; dd; 6-0

122.5

125.7

16.

7.44; 1H; dd; 6-0

121.4

122.3

17.

1.89; 1.59; 2H; dtd

39.7

40.0

18.

1.79; 1H; m*

24.4

24.5

19.

0.65; 3H; d; 6

23.1

23.2

20.

0.65; 3H; d; 6

20.6

20.6

21.

-

---

---

22.

-

165.2

23.

6.49; 1H; d; 12

130.6

127.8

24.

8.11; 1H; d; 18

140.9

143.3

25.

-

122.9

26.

7.56; 1H; d, 6

127.8

127.8

27.

7.29; 1H; dd, 6-0

129.1

130.4

28.

7.29; 1H; dd, 6-0

129.8

127.9

29.

7.29; 1H; dd, 6-0

129.1

130.4

30.

7.56; 1H; d, 6

127.8

127.8

31.

2.47; 1H; m*

29.5

29.5

32.

1.20; 3H; d; 6

20.3

20.0

33.

1.23; 3H; d; 6

14.8

14.7

4. Conclusion
This study isolated and characterized secondary metabolites from Ziziphus mauritiana fruit and evaluated their antibacterial potential against Staphylococcus aureus, including reference strains and a clinical isolate. The work demonstrated that the crude extract (ZSA), as well as certain fractions, notably the alkaloid fraction F3, exhibited significant anti-staphylococcal activity, with minimum inhibitory concentrations (MICs) reaching up to 15.6 µg/mL against the S. aureus strain ATCC 25923. The activity of the crude extract, superior to that of some isolated fractions, suggests a promising synergistic effect between the different fruit constituents.
Among the identified compounds, sanjoinenin (1), betulinic acid (3), and epicatechin (4) were fully characterized by advanced spectroscopic methods (1D and 2D NMR). These molecules, belonging to the classes of cyclopeptide alkaloids, triterpenes, and flavonoids, are known for their diverse biological properties and could contribute to the observed activity.
These results validate the traditional use of Ziziphus mauritiana in the treatment of bacterial infections and highlight its potential as a source of compounds active against S. aureus, a priority pathogen due to the increasing prevalence of resistant strains, including MRSA. The promising MICs, particularly of the crude extract, warrant further investigation to isolate other active constituents, evaluate their mechanisms of action, and study their in vivo efficacy as well as their potential toxicity. This research thus paves the way for the development of new natural antimicrobial agents or complementary phytomedicines in the fight against staphylococcal infections.
Acknowledgments
At the end of this work, we would like to warmly thank the manager of LANAPOS Mr EPHREM Augustin Nkengfack who allowed us not only to work on the subject of thesis by inviting us to the University of Yaouande Ⅰ, but who is also our co-supervisor. Our thanks also go to Mm Ouahouo wache Blandine and Haroun Heloua Drame who have made a great scientific contribution in this article. Finally, we thank the colleagues of the Laboratory of Natural Products and Applied Organic Synthesis.
Conflicts of Interest
The authors declare no conflicts of interest.
References
[1] Wierzchowska, K. (2023). The Occurrence of Methicillin-Resistant Staphylococcus Aureus (MRSA) Around the World and Antibiotic Therapy for Selected Infections Caused By MRSA. Postepy Mikrobiologii, 62(2), 101–111.
[2] Lee, A. S., Lee, A. S., de Lencastre, H., de Lencastre, H., Garau, J., Kluytmans, J., Malhotra-Kumar, S., Peschel, A., & Harbarth, S. J. (2018). Methicillin-resistant Staphylococcus aureus. 4(1), 18033.
[3] Falagas, M. E., Karageorgopoulos, D. E., Leptidis, J., & Korbila, I. P. (2013). MRSA in Africa: filling the global map of antimicrobial resistance. PLOS ONE, 8(7).
[4] Eshetie S., Tarekegn F., Moges F., Amsalu A., Birhan W., Huruy K (2016). Methicillin resistant Staphylococcus aureus in Ethiopia: a meta-analysis. BMC Infection Disease 16: 689 694.
[5] Bérdy J., (2005). Bioactive microbial metabolites. Journa of Antibiotic 58: 1– 26.
[6] Lei Yang L., Yang C., Li C., Zhao Q., Liu L., Fang X., Ya Chen X (2016). Recent advances in biosynthesis of bioactive compounds in traditional Chinese medicinal plants. Sciences Bull. 61: 3–17.
[7] Said A., Huefner A., Tabl E., & Fawzy G., (2006). Two new cyclic amino acids from the seeds and antiviral activity of methanolic extract of the roots of Zizyphus spina-christi. Paper presented at the 54th Annual Congress on Medicinal Plant Research. Planta Medica, 72, 222.
[8] Jaradat, N. (2005). Medical Plants Utilized in Palestinian Folk Medicine for Treatment of Diabetes Mellitus and Cardiac diseases.
[9] Saied, A. S., Gebauer, J., Hammer, K., & Buerkert, A. (2008). Ziziphus spina-christi (L.) Willd.: a multipurpose fruit tree. Genetic resources and crop evolution, 55(7), 929-937.
[10] Abalaka M. E., Daniyan S. Y., Mann A., (2010). Evaluation of the antimicrobial activities of two Ziziphus species (Ziziphus mauritiana L. and Ziziphus spina christi L.) on some microbialpathogens. African Journal of Pharmacy and Pharmacology, 4(4): 135-139.
[11] Harikrishnan, R., & Balasundaram, C. (2020). Potential of herbal extracts and bioactive compounds for human healthcare. In The Role of Phytoconstitutents in Health Care (pp. 3-158). Apple Academic Press.
[12] Irfanitha, I., Naid, T., & Nuryanti, S. (2024). Aktivitas Antibakteri Ekstrak Metanol Daun Bidara (Ziziphus mauritiana Lam) Terhadap Bakteri Uji Penyebab Luka Infeksi Dengan Metode Difusi Agar. 2(1), 182–192.
[13] Jiamboonsri, P., Pithayanukul, P., Bavovada, R., & Traidej Chomnawang, M. (2011). The Inhibitory Potential of Thai Mango Seed Kernel Extract against Methicillin-Resistant Staphylococcus Aureus. Molecules, 16(8), 6255–6270.
[14] Joray, M. B., González, M. L., Palacios, S. M., & Carpinella, M. C. (2011). Antibacterial activity of the plant-derived compounds 23-methyl-6-O-desmethylauricepyrone and (Z, Z)-5-(trideca-4, 7-dienyl) resorcinol and their synergy with antibiotics against methicillin-susceptible and -resistant Staphylococcus aureus. Journal of Agricultural and Food Chemistry, 59(21), 11534–11542.
[15] Mm, A., Am, M., Ia, U., Da, A., Joseph, I., Louis, H., & Amos, P. I. (2017). Phytochemical Screening and Antimicrobial Activity of the Pulp Extract and Fractions of Ziziphus mauritiana. Biochemistry & Analytical Biochemistry, 7(2), 1–6.
[16] Pájaro-González, Y., Oliveros-Díaz, A., Cabrera-Barraza, J., Fernández-Daza, E., Reyes, N., Montes-Guevara, O. A., Caro-Fuentes, D., Franco-Ospina, L. A., Quiñones-Fletcher, W., Quave, C. L., & Díaz-Castillo, F. (2022). Mammea B/BA Isolated From the Seeds of Mammea americana L. (Calophyllaceae) is a Potent Inhibitor of Methicillin-Resistant Staphylococcus aureus. Frontiers in Pharmacology, 13.
[17] Samsi, A. S., & Suriati, I. (2023). Uji Aktivitas Antibakter Formulasi Sediaan Salep Ekstrak Daun Bidara (Ziziphus mauritania) terhadap Bakteri Staphylococcus aureus. Indonesian Journal of Pharmaceutical Education, 3(2).
[18] Sorres, J., André, A., Van Elslande, E., Stien, D., & Eparvier, V. (2020). Potent and Non-Cytotoxic Antibacterial Compounds Against Methicillin-Resistant Staphylococcus aureus Isolated from Psiloxylon mauritianum, A Medicinal Plant from Reunion Island. Molecules, 25(16), 3565.
[19] Syafa’atulloh, M. Y., Setiawati, Y., & Retnowati, W. (2022). In Vitro Study of Antibacterial Activity of Bidara Leaf Extract (Ziziphus mauritiana) against Staphylococcus aureus and MRSA. International Journal of Research Publications, 113(1).
[20] Zamzam, M. Y., Rohadi, D., & Rizkyan, A. W. (2024). UJI AKTIVITAS ANTIBAKTERI EKSTRAK ETANOL TERPURI-FIKASI DAUN BIDARA ARAB (Ziziphus spina-christi L.) TERHADAP BAKTERI Staphylococcus aureus. Medimuh, 5(1), 15–26.
[21] AL-Salman, H. N., Ali, E. T., Almukhtar, O. A., & Jabir, M. S. (2020). 2-benzhydrylsulfinyl-N-hydroxyacetamide extracted from fig: A good therapeutic agent against Staphylococcus aureus. 2213, 020223.
[22] Abu-Zarga M., Salim S., AL-Aboudi A., Saleh A. M., Naheed S. and Atta-Ur-Rahman, (April 1995). New cyclopeptide alkaloids from Ziziphus lotus. Journal of Natural Products Vol. 58, No. 4: 504-511.
[23] Tuenter E., Exarchou V., Balde A., Cos P., Maes L., Aper S. and Pieters L., 2016. Cyclopeptide alkaloids from Hymenocardia acida. Journal of Natural Product 79(7): 1746- 1751.
[24] Han, B. H., & Boudjouk, P. (1982). Organic sonochemistry. Sonic acceleration of the Reformatsky reaction. The Journal of Organic Chemistry, 47(25), 5030-5032.
Cite This Article
  • APA Style

    Mahamat, A. A., Adannou, H. A., Heloua, H., Mbarga, P. E., Blandine, O. W., et al. (2026). Anti-Staphylococcus Aureus Guide Isolation of Compounds from the Fruits of Ziziphus Mauritiana. American Journal of Applied Chemistry, 14(1), 1-10. https://doi.org/10.11648/j.ajac.20261401.11

    Copy | Download

    ACS Style

    Mahamat, A. A.; Adannou, H. A.; Heloua, H.; Mbarga, P. E.; Blandine, O. W., et al. Anti-Staphylococcus Aureus Guide Isolation of Compounds from the Fruits of Ziziphus Mauritiana. Am. J. Appl. Chem. 2026, 14(1), 1-10. doi: 10.11648/j.ajac.20261401.11

    Copy | Download

    AMA Style

    Mahamat AA, Adannou HA, Heloua H, Mbarga PE, Blandine OW, et al. Anti-Staphylococcus Aureus Guide Isolation of Compounds from the Fruits of Ziziphus Mauritiana. Am J Appl Chem. 2026;14(1):1-10. doi: 10.11648/j.ajac.20261401.11

    Copy | Download

  • @article{10.11648/j.ajac.20261401.11,
      author = {Aboubakar Ali Mahamat and Haroun Ali Adannou and Haroun Heloua and Paul Etoga Mbarga and Ouahouo Wache Blandine and Pierre Mkounga and Ephrem Augustin Nkengfack},
      title = {Anti-Staphylococcus Aureus Guide Isolation of Compounds from the Fruits of Ziziphus Mauritiana},
      journal = {American Journal of Applied Chemistry},
      volume = {14},
      number = {1},
      pages = {1-10},
      doi = {10.11648/j.ajac.20261401.11},
      url = {https://doi.org/10.11648/j.ajac.20261401.11},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajac.20261401.11},
      abstract = {The present work deals with the isolation, purification and characterization of secondary metabolites of the fruits of Ziziphus mauritiana and the evaluation of their biological activity against Staphylococcus aureus. A plant from the Rhamnaceae family, widely used in the Cameroonian and Tchadian traditional pharmacopoeia for the treatment of various diseases such as food poisoning, pneumonia, urinary tract infections, and skin infections such as wounds and ulcers. Our investigations focused on the methanol/dichloromethane (MeOH/DCM, 1:1) extract of the fruits of Ziziphus mauritiana. Alkaloidal treatment was performed on this extract, and we obtained four (04) fractions: two non-alkaloid fractions, F1 (DCM), F2 (EtOAc), and two alkaloid fractions, F3 (DCM) and F4 (EtOAc). Using usual chromatographic methods (CC, CCM), we isolated from the alkaloidal fraction F3, two compounds 1 and 2, and four compounds 3, 4, 5, 6 from the non-alkaloid fraction F1, the hexane fraction. From these compounds, three (03) were fully characterized using spectroscopic methods 1H and 13C NMR (1 and 2 dimensions) and by comparison of their spectral data with those of the literature. These are: Sanjoinenine 1, betulinic acid 3, and epicatechin 4. The crude extract as well as fraction, and some isolated compounds were evaluated in vitro by the liquid microdilution method described by CLSI, against two strains of Staphylococcus aureus: S. aureus ATCC25923, S. aureus ATCC43300, and a Clinical isolate. The crude extract, fractions F1 and F4, were the most active fractions tested against the strain S. aureus ATCC 25923, with a MIC of 15.6, 62.5, and 15.6 µg/mL, respectively, while the other fractions (F2 and F3) showed moderate activity against the same strain. Fraction F2 is not active. For the S. aureus ATCC 43300, all the fractions have a weak activity, and for the clinical isolate, only ZSA shows a good activity with a MIC of 62.5 µg/mL, and the others show a moderate activity.},
     year = {2026}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Anti-Staphylococcus Aureus Guide Isolation of Compounds from the Fruits of Ziziphus Mauritiana
    AU  - Aboubakar Ali Mahamat
    AU  - Haroun Ali Adannou
    AU  - Haroun Heloua
    AU  - Paul Etoga Mbarga
    AU  - Ouahouo Wache Blandine
    AU  - Pierre Mkounga
    AU  - Ephrem Augustin Nkengfack
    Y1  - 2026/01/30
    PY  - 2026
    N1  - https://doi.org/10.11648/j.ajac.20261401.11
    DO  - 10.11648/j.ajac.20261401.11
    T2  - American Journal of Applied Chemistry
    JF  - American Journal of Applied Chemistry
    JO  - American Journal of Applied Chemistry
    SP  - 1
    EP  - 10
    PB  - Science Publishing Group
    SN  - 2330-8745
    UR  - https://doi.org/10.11648/j.ajac.20261401.11
    AB  - The present work deals with the isolation, purification and characterization of secondary metabolites of the fruits of Ziziphus mauritiana and the evaluation of their biological activity against Staphylococcus aureus. A plant from the Rhamnaceae family, widely used in the Cameroonian and Tchadian traditional pharmacopoeia for the treatment of various diseases such as food poisoning, pneumonia, urinary tract infections, and skin infections such as wounds and ulcers. Our investigations focused on the methanol/dichloromethane (MeOH/DCM, 1:1) extract of the fruits of Ziziphus mauritiana. Alkaloidal treatment was performed on this extract, and we obtained four (04) fractions: two non-alkaloid fractions, F1 (DCM), F2 (EtOAc), and two alkaloid fractions, F3 (DCM) and F4 (EtOAc). Using usual chromatographic methods (CC, CCM), we isolated from the alkaloidal fraction F3, two compounds 1 and 2, and four compounds 3, 4, 5, 6 from the non-alkaloid fraction F1, the hexane fraction. From these compounds, three (03) were fully characterized using spectroscopic methods 1H and 13C NMR (1 and 2 dimensions) and by comparison of their spectral data with those of the literature. These are: Sanjoinenine 1, betulinic acid 3, and epicatechin 4. The crude extract as well as fraction, and some isolated compounds were evaluated in vitro by the liquid microdilution method described by CLSI, against two strains of Staphylococcus aureus: S. aureus ATCC25923, S. aureus ATCC43300, and a Clinical isolate. The crude extract, fractions F1 and F4, were the most active fractions tested against the strain S. aureus ATCC 25923, with a MIC of 15.6, 62.5, and 15.6 µg/mL, respectively, while the other fractions (F2 and F3) showed moderate activity against the same strain. Fraction F2 is not active. For the S. aureus ATCC 43300, all the fractions have a weak activity, and for the clinical isolate, only ZSA shows a good activity with a MIC of 62.5 µg/mL, and the others show a moderate activity.
    VL  - 14
    IS  - 1
    ER  - 

    Copy | Download

Author Information
  • Department of Organic Chemistry, University of Yaoundé I, Yaoundé, Cameroon

  • Department of Exact and Applied Sciences, Higher Teacher Training College of N'Djamena, N'djamena, Chad

  • Department of Chemistry, University of N'Djamena, N'Djamena, Chad

  • Department of Organic Chemistry, University of Yaoundé I, Yaoundé, Cameroon

  • Department of Organic Chemistry, University of Yaoundé I, Yaoundé, Cameroon

  • Department of Organic Chemistry, University of Yaoundé I, Yaoundé, Cameroon

  • Department of Organic Chemistry, University of Yaoundé I, Yaoundé, Cameroon

  • Abstract
  • Keywords
  • Document Sections

    1. 1. Introduction
    2. 2. Materiel et Method
    3. 3. Results and Discussion
    4. 4. Conclusion
    Show Full Outline
  • Acknowledgments
  • Conflicts of Interest
  • References
  • Cite This Article
  • Author Information